Mumbai, Jun 23 (UNI) Patni Computer Systems, a leading IT services provider, today announced the availability of its new software solution to the pharma industry for performing adverse event case processing.
PatniADEPT, announced today at the 44th annual Drug Information Association (DIA) conference in Boston, addresses the challenges life science companies face, due to increased pressure from regulators, to tighten reporting structures and from the marketplace to avoid costly missteps in the drug production cycle, the company said in a release here.
The solution, delivered by Patni Life Sciences, is one of the first to provide a cost-effective, unique service for drug makers and pharmaceutical customers of all sizes, with an integrated ITO and BPO capability to improve and streamline case processing functions.
PatniADEPT leverages industry-leading software that provides hosted support for the global collection, coding, assessment and reporting of adverse event data.
Additionally, PatniADEPT incorporates Signal Intelligence-PV, Patni's advanced visualisation tool, for signal detection and data mining. This tool delivered intuitive analysis of the company's safety data, plus a comparison to related safety information in the FDA's Adverse Event Reporting System (AERS), a computerised information database designed to support the FDA's post-marketing safety surveillance program, for all approved drug and therapeutic biologic products. The integrated approach ensures compliance with FDA's Good Pharmacovigilance Practices.
UNI VK SR AG1845